Chirality of a 1,10-bisacetoxymitosene compound. Impact on reductive activation, DNA interstrand cross-linking and antitumour activity

M. Maliepaard, S.E. Groot, N.J. de Mol, L.H.M. Janssen, M. Freriks, Willem Verboom, David Reinhoudt, I.J. Stratford

Research output: Contribution to journalArticleAcademicpeer-review

4 Citations (Scopus)
17 Downloads (Pure)
Original languageUndefined
Pages (from-to)403-413
JournalAnti-cancer drug design
Volume11
Issue number11
Publication statusPublished - 1996

Keywords

  • METIS-105919
  • IR-10950

Cite this

Maliepaard, M., Groot, S. E., de Mol, N. J., Janssen, L. H. M., Freriks, M., Verboom, W., ... Stratford, I. J. (1996). Chirality of a 1,10-bisacetoxymitosene compound. Impact on reductive activation, DNA interstrand cross-linking and antitumour activity. Anti-cancer drug design, 11(11), 403-413.